Loading…
20 Microns (20MICRONS)₹187.33+0.14%Industrial Minerals
In the Sep 2026 quarter (consolidated), 20 Microns reported sales of ₹239 Cr, up 3.0% from Sep 2025, and net profit of ₹13.98 Cr, down 17.6% year on year. For the year to Mar 2026, sales were ₹957 Cr and net profit ₹66.93 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 175 | 212 | 232 | 241 | 215 | 227 | 248 | 232 | 215 | 262 | 246 | 239 |
| Expenses | 153 | 186 | 201 | 209 | 188 | 199 | 216 | 199 | 187 | 229 | 213 | 211 |
| Operating Profit | 22.01 | 27.01 | 29.99 | 31.01 | 26.01 | 29.02 | 32.02 | 32.01 | 27.99 | 31.99 | 32.02 | 27.01 |
| OPM % | 12.9% | 11.9% | 13.0% | 12.9% | 12.0% | 12.9% | 13.0% | 14.0% | 13.0% | 11.9% | 13.0% | 12.0% |
| Other Income | 0.00 | 0.99 | 1.99 | 0.99 | 0.99 | 0.00 | 0.99 | 1.99 | 0.99 | 1.99 | 0.99 | 0.99 |
| Interest | 4.01 | 4.99 | 3.99 | 4.01 | 5.01 | 5.01 | 5.01 | 4.01 | 4.01 | 4.01 | 3.99 | 3.99 |
| Depreciation | 3.98 | 3.99 | 3.99 | 4.99 | 4.98 | 4.99 | 4.98 | 4.98 | 4.98 | 4.98 | 4.98 | 4.98 |
| Profit before tax | 14.99 | 18.98 | 23.97 | 22.95 | 16.98 | 18.97 | 22.99 | 22.98 | 19.98 | 23.96 | 23.96 | 18.99 |
| Tax % | 25.1% | 29.0% | 26.1% | 27.1% | 23.1% | 20.1% | 26.0% | 26.0% | 25.0% | 28.0% | 27.1% | 29.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | −0.11 | −0.69 | −0.18 | −0.01 | 0.00 | −0.16 | −0.09 | 0.00 | 0.00 |
| Net Profit | 11.99 | 13.97 | 17.97 | 15.98 | 12.98 | 14.97 | 16.99 | 16.97 | 14.99 | 17.98 | 17.99 | 13.98 |
| EPS (Rs) | 3.26 | 3.88 | 5.07 | 4.66 | 3.66 | 4.32 | 4.79 | 4.94 | 4.25 | 5.00 | 5.05 | 3.88 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 358 | 393 | 428 | 482 | 531 | 485 | 615 | 704 | 779 | 915 | 957 | 962 |
| Expenses | 310 | 337 | 367 | 411 | 463 | 425 | 534 | 616 | 672 | 795 | 830 | 839 |
| Operating Profit | 46.04 | 56.05 | 60.01 | 69.07 | 66.03 | 59.04 | 78.99 | 86.05 | 106 | 117 | 123 | 119 |
| OPM % | 13.0% | 14.0% | 14.0% | 14.0% | 11.9% | 11.9% | 13.0% | 11.9% | 13.9% | 12.9% | 12.9% | 12.4% |
| Other Income | 3.99 | 1.99 | 0.99 | 1.99 | 2.99 | 1.99 | 1.99 | 2.99 | 1.99 | 1.99 | 5.98 | 4.96 |
| Interest | 25.03 | 24.01 | 22.01 | 21.99 | 21.99 | 25.01 | 19.99 | 18.02 | 15.99 | 18.01 | 17.01 | 16.00 |
| Depreciation | 9.97 | 9.97 | 9.97 | 9.96 | 12.95 | 13.95 | 13.95 | 13.95 | 13.95 | 17.95 | 20.92 | 19.92 |
| Profit before tax | 13.99 | 22.97 | 27.97 | 37.94 | 34.97 | 21.98 | 47.98 | 56.90 | 76.92 | 82.87 | 90.83 | 86.89 |
| Tax % | 24.1% | 31.1% | 32.1% | 35.0% | 30.0% | −6.0% | 27.0% | 27.1% | 27.0% | 24.1% | 26.0% | — |
| Exceptional items | 0.99 | 0.00 | −0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.99 | −1.99 | 0.00 | −0.25 |
| Net Profit | 10.98 | 15.98 | 18.99 | 24.96 | 23.96 | 22.98 | 34.96 | 41.91 | 55.89 | 61.87 | 66.93 | 64.94 |
| EPS (Rs) | 3.12 | 4.50 | 5.35 | 7.09 | 6.85 | 6.52 | 9.81 | 11.87 | 15.92 | 17.70 | 18.96 | 18.18 |
| Dividend payout % | 0.0% | 0.0% | 14.0% | 0.0% | 9.0% | 0.0% | 0.0% | 6.0% | 8.0% | 7.0% | 7.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 16.97 | 17.96 | 17.98 | 17.96 | 17.95 | 17.98 | 17.95 | 17.98 | 17.96 | 17.96 | 17.96 | 17.96 |
| Reserves | 53.95 | 69.85 | 107 | 126 | 150 | 170 | 197 | 234 | 276 | 334 | 412 | 466 |
| Borrowings | 165 | 163 | 152 | 134 | 124 | 119 | 104 | 123 | 108 | 121 | 165 | 156 |
| Other Liabilities | 97.52 | 82.60 | 85.68 | 97.53 | 111 | 136 | 132 | 139 | 120 | 113 | 118 | 114 |
| Total Liabilities | 333 | 333 | 363 | 375 | 403 | 443 | 451 | 513 | 522 | 587 | 712 | 754 |
| Fixed Assets | 151 | 151 | 177 | 185 | 195 | 201 | 203 | 207 | 213 | 212 | 284 | 297 |
| CWIP | 7.02 | 4.01 | 7.02 | 8.02 | 4.01 | 11.04 | 3.01 | 5.01 | 8.03 | 12.03 | 9.02 | 13.03 |
| Investments | 0.99 | 0.99 | 1.99 | 2.99 | 3.99 | 1.99 | 5.99 | 8.99 | 9.01 | 17.01 | 24.99 | 19.01 |
| Other Assets | 173 | 177 | 176 | 178 | 200 | 229 | 239 | 292 | 292 | 345 | 394 | 426 |
| Inventories | 65.85 | 69.82 | 67.82 | 71.87 | 83.86 | 97.70 | 101 | 129 | 115 | 113 | 160 | 142 |
| Trade receivables | 50.16 | 56.18 | 60.13 | 66.21 | 70.22 | 82.29 | 90.30 | 100 | 97.24 | 126 | 143 | 178 |
| Cash & equivalents | 17.93 | 8.96 | 9.96 | 8.97 | 10.97 | 7.97 | 9.96 | 16.94 | 29.89 | 59.80 | 37.86 | 81.77 |
| Total Assets | 333 | 333 | 363 | 375 | 403 | 443 | 451 | 513 | 522 | 587 | 712 | 754 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 29.93 | 24.92 | 43.89 | 60.87 | 52.85 | 44.85 | 51.89 | 34.90 | 62.82 | 53.87 | 31.93 | 104 |
| Cash from investing activity | −4.01 | −6.01 | −9.02 | −18.04 | −19.04 | −16.05 | −9.02 | −23.07 | −18.06 | −23.06 | −59.15 | −31.07 |
| Cash from financing activity | −21.07 | −26.09 | −34.13 | −44.15 | −33.11 | −30.12 | −45.16 | −4.02 | −38.15 | −3.01 | 10.03 | −30.10 |
| Net cash flow | 5.99 | −5.99 | 1.99 | −1.01 | 1.99 | −0.99 | −1.99 | 9.01 | 7.99 | 27.99 | −17.01 | 41.99 |
| Capex | 5.47 | 7.32 | 11.22 | 19.64 | 19.73 | 16.57 | 10.44 | 27.33 | 12.47 | 19.84 | 76.51 | 26.32 |
| Free cash flow | 26.02 | 20.01 | 33.03 | 41.02 | 35.04 | 29.03 | 42.02 | 12.01 | 52.07 | 35.02 | −44.07 | 78.06 |
| CFO / OP % | 105.0% | 58.1% | 91.1% | 110.0% | 89.0% | 83.0% | 100.1% | 59.0% | 92.1% | 68.0% | 45.0% | 104.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 50 | 56 | 55 | 56 | 52 | 56 | 67 | 59 | 50 | 58 | 56 | 67 |
| Inventory days | 126 | 150 | 133 | 132 | 134 | 128 | 144 | 148 | 115 | 99 | 120 | 102 |
| Days payable | 138 | 118 | 105 | 113 | 106 | 115 | 134 | 113 | 79 | 54 | 51 | 44 |
| Cash conversion cycle | 39 | 90 | 84 | 77 | 80 | 69 | 78 | 94 | 87 | 104 | 126 | 126 |
| Working capital days | −27 | −6 | −4 | 6 | 11 | 18 | 24 | 31 | 34 | 39 | 46 | 45 |
| ROCE % | 9.0% | 16.0% | 18.1% | 19.0% | 21.0% | 19.0% | 15.0% | 19.1% | 19.0% | 22.0% | 19.0% | 17.0% |
For the Sep 2026 quarter, 20 Microns reported sales of ₹239 Cr, up 3.0% year on year and net profit of ₹13.98 Cr, down 17.6% year on year. The operating margin was 12.0%.
20 Microns' sales for the year to Mar 2026 were ₹957 Cr; over the last twelve months they were ₹962 Cr.
Net profit for the year to Mar 2026 was ₹66.93 Cr, and ₹64.94 Cr over the last twelve months. Earnings per share over the same trailing period were ₹18.18.
20 Microns reported borrowings of ₹156 Cr at Mar 2026, against cash and equivalents of ₹81.77 Cr.
Cash from operations was ₹104 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹78.06 Cr.